Aytu Biopharma (AYTU) Acquisitions (2015 - 2021)

Aytu Biopharma (AYTU) has 5 years of Acquisitions data on file, last reported at -$202000.0 in Q2 2021.

• Acquisitions for Q2 2021 came in at -$202000.0, down 240576.19% year-over-year; the trailing twelve-month figure through Jun 2021 was -$5.6 million (down 3.75% YoY), and the FY2021 annual result was $15.5 million, up 3869.31% from the prior year.
• Acquisitions declined to -$202000.0 in Q2 2021 per AYTU's latest filing, from $15.4 million in the prior quarter.
• Over five years, Acquisitions peaked at $15.4 million in Q1 2021 and troughed at -$5.4 million in Q2 2017.
• A 3-year average of $2.4 million and a median of -$100958.0 in 2020 frame the typical range for Acquisitions.
• On a YoY basis, Acquisitions climbed as much as 240576.19% in 2021 and fell as far as 240576.19% in 2021.
• A 3-year view of Acquisitions shows it stood at -$5.4 million in 2017, then jumped by 100.0% to $84.0 in 2020, then plunged by 240576.19% to -$202000.0 in 2021.
• Business Quant data shows AYTU's Acquisitions at -$202000.0 in Q2 2021, $15.4 million in Q1 2021, and $84.0 in Q2 2020.